JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David C. McGiffin
Timo Savunen
James K. Kirklin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGiffin, D. C.
Right arrow Articles by Early, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGiffin, D. C.
Right arrow Articles by Early, L.

J Thorac Cardiovasc Surg 1995;109:1081-1089
© 1995 Mosby, Inc.


CARDIAC AND PULMONARY REPLACEMENT

Cardiac transplant coronary artery disease: A multivariable analysisof pretransplantation risk factors for disease development and morbid events

David C. McGiffin, MDa(by invitation), Timo Savunen, MDa (by invitation), James K. Kirklin, MDa, David C. Naftel, PhDa(by invitation), Robert C. Bourge, MDb(by invitation), Thomas D. Paine, MDb(by invitation), Connie White-Williams, RNa(by invitation), Tero Sisto, MDa (by invitation), Lesley Early, RNa (by invitation)


Birmingham, Ala.

From the Division of Cardiothoracic Surgery, Department of Surgery,a and the Division of Cardiology, Department of Medicine,bUniversity of Alabama at Birmingham, Birmingham, Ala.

Address for reprints: David C. McGiffin, MD, Associate Professorof Surgery, University of Alabama at Birmingham, Birmingham, AL 35294.

Abstract

Coronary artery disease after cardiac transplantationis a major obstacle to long-term survival. The development and progressionof coronary artery disease after cardiac transplantation was analyzed in 217consecutive patients undergoing transplantation. The actuarial freedom fromany coronary artery disease (by angiography or autopsy) was 81% at 2 yearsand 20% at 8 years after transplantation. Coronary artery disease was moreprevalent in male than female patients (30% versus 50% free of coronary arterydisease at 5 years, p = 0.01). By multivariable analysis, pretransplantationrisk factors identified for coronary artery disease included pretransplantationpositive cytomegalovirus serologic status of the recipient (p = 0.002) and older donor age (p= 0.07). Progression of coronary artery disease was variable in both timeof onset and rate. Earlier detection did not result in more rapid progression.Coronary events severe enough for retransplantation (n = 8) and/or death from coronary artery disease (n = 9) occurred in 15 patients, of whom four underwent retransplantation.The actuarial freedom from coronary events was 88% at 5 years and 79% at 8years. By multivariable analysis, only male recipient (p = 0.05) was a risk factor for coronary events. Seven of the 15patients (47%) with coronary events died suddenly of coronary artery diseasewithout prior angiographic evidence of severe coronary disease. Coronary arterydisease is progressive. Improved surveillance methods are required to detectthe disease and institute timely intervention to prevent the occurrence ofunanticipated death. (J THORAC CARDIOVASC SURG 1995;109:1081-9)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Schmidt-Lucke, A. Aicher, P. Romagnani, B. Gareis, S. Romagnani, A. M. Zeiher, and S. Dimmeler
Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2425 - H2431.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Hussain, M. Burch, M. J. Fenton, P. M. Whitmore, P. Rees, M. Elliott, and P. Aurora
Positive Pretransplantation Cytomegalovirus Serology Is a Risk Factor for Cardiac Allograft Vasculopathy in Children
Circulation, April 3, 2007; 115(13): 1798 - 1805.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Circulation, December 12, 2006; 114(24): 2710 - 2738.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
D. J. Kutsogiannis, G. Pagliarello, C. Doig, H. Ross, and S. D. Shemie
Medical management to optimize donor organ potential: review of the literature: [Traitement medical pour optimaliser le potentiel de don d'organe : une revue documentaire].
Can J Anesth, August 1, 2006; 53(8): 820 - 830.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. D. Shemie, H. Ross, J. Pagliarello, A. J. Baker, P. D. Greig, T. Brand, S. Cockfield, S. Keshavjee, P. Nickerson, V. Rao, et al.
Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential.
Can. Med. Assoc. J., March 14, 2006; 174(6): S13 - S32.
[Full Text] [PDF]


Home page
CMAJHome page
S. D. Shemie, H. Ross, J. Pagliarello, A. J. Baker, P. D. Greig, T. Brand, S. Cockfield, S. Keshavjee, P. Nickerson, V. Rao, et al.
La prise en charge des donneurs d'organes au Canada : recommandations du forum Optimiser le maintien du donneur afin d'accroitre le nombre d'organes admissibles pour la transplantation
Can. Med. Assoc. J., March 14, 2006; 174(6): SF14 - SF32.
[Full Text] [PDF]


Home page
CirculationHome page
D. Mancini, S. Pinney, D. Burkhoff, J. LaManca, S. Itescu, E. Burke, N. Edwards, M. Oz, and A. R. Marks
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy
Circulation, July 8, 2003; 108(1): 48 - 53.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Wenke, B. Meiser, J. Thiery, D. Nagel, W. von Scheidt, K. Krobot, G. Steinbeck, D. Seidel, and B. Reichart
Simvastatin Initiated Early After Heart Transplantation: 8-Year Prospective Experience
Circulation, January 7, 2003; 107(1): 93 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Kapadia, S. E. Nissen, K. M. Ziada, G. Rincon, T. D. Crowe, N. Boparai, J. B. Young, and E. M. Tuzcu
Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. J. Hauptman, K. J. O'Connor, R. E. Wolf, and B. J. McNeil
Angiography of potential cardiac donors
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1252 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. W. Stevenson and R. L. Kormos
Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 340 - 370.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.